Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor
US4933156A · kind A · utility
27Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 1988 |
| Grant date | Jun 12, 1990 |
| Priority date | — |
| Expiry date | Apr 6, 2008 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The presence and location of amyloid deposits in an organ or body area of a patient is effected by intravenous administration of novel radioactive iodine-labeled amyloid binding compounds and preferably .sup.123 I-labeled compounds to the patient and sensing radiation emitted from the organ or body area. Novel non-radioactive iodine substituted amyloid binding compounds and amyloid binding compounds which are readily iodinated are further aspects of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.